Quadruple aim in mHealth project to improve the control of cardiovascular risk factors in a very high-risk population
e202207056
Keywords:
Cardiovascular prevention, Ischemic heart disease, Cardiovascular risk, Cardiac rehabilitation, Triple aimAbstract
BACKGROUND // The control of cardiovascular (CV) risk factors in high-risk population is still suboptimal. This fact should make us reconsider current preventive strategies. The objective of this study was to transform the secondary cardiovascular prevention program of the University Hospital of Torrejon (Madrid, Spain), to make it more proactive, preventive, productive and efficient.
METHODS // Within the quadruple aim perspective, we present a mHealth project where the patient will include, and periodically review, the parameters and values related to the main CV risk factors (smoking, diet, physical activity, weight, blood pressure, LDL cholesterol and glycosylated hemoglobin), allowing to check if therapeutic objectives recommended in the clinical practice guidelines are achieved, facilitating doctor-patient communication, and generating warnings to reinforce indications and/or intensify the therapeutic and pharmacological measures in case of non-complianc.
RESULTS // A detailed evaluation of the achievement of quadruple aim goals will be performed. Improvements in CV risk control, experience in care, health spending and the healthcare professionals’ satisfaction will be assessed.
CONCLUSIONS // mHealth offers new opportunities to improve the control of CV risk factors in high-risk patients. Better control might reduce the high cardiovascular morbidity and mortality of this population, helping to reduce health spending and improving the patients’ experience and adherence to secondary prevention strategies.
Downloads
References
Instituto Nacional de Estadística. Defunciones según la Causa de Muerte. Año 2018. Notas de prensa 2019. [consultado 2021 Oct 10]. Disponible en: https://www.ine.es/prensa/edcm_2018.pdf
Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254-e743.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315-2381.
Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26:824-835.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982-3021.
Chow CK, Ariyarathna N, Islam SMS, Thiagalingam A, Redfern J. mHealth in Cardiovascular Health Care. Heart Lung Circ. 2016;25:802-807.
Schorr EN, Gepner AD, Dolansky MA, Forman DE, Park LG, Petersen KS et al. Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2021;14:e000103.
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27:759-769.
Zoghbi WA. President’s page: working toward the triple aim in cardiovascular health care. J Am Coll Cardiol. 2012;59:1655-1657.
Valentine CM. Tackling the Quadruple Aim: Helping Cardiovascular Professionals Find Work-Life Balance. J Am Coll Cardiol. 2018;71:1707-1709.
Alami H, Lehoux P, Gagnon MP, Fortin JP, Fleet R, Ag Ahmed MA. Rethinking the electronic health record through the quadruple aim: time to align its value with the health system. BMC Med Inform Decis Mak. 2020;20:32-35.
Stiefel M, Nolan K. A Guide to Measuring the Triple Aim: Population Health, Experience of Care, and Per Capita Cost. IHI Innovation Series white paper. Cambridge, Massachusetts: Institute for Healthcare Improvement; 2012. (disponible en www.IHI.org).
Crossing the Quality Chasm: A New Health System for the 21st Century. Committee on Quality of Health Care in America, Institute of Medicine, Washington, DC, USA. National Academies Press; 2001.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–188.
Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Dorobantu M et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;00:1–79.
Murphy AC, Meehan G, Koshy AN, Kunniardy P, Farouque O, Yudi MB. Efficacy of Smartphone-Based Secondary Preventive Strategies in Coronary Artery Disease. Clinical Medicine Insights: Cardiology. 2020;14:1-7.
Akinosun AS, Polson R, Diaz-Skeete Y, De Kock JH, Carragher L, Leslie S et al. Digital Technology Interventions for Risk Factor Modification in Patients With Cardiovascular Disease: Systematic Review and Meta-analysis. JMIR Mhealth Uhealth. 2021;9:e21061.
Neubeck L, Lowres N, Benjamin EJ, Freedman SB, Coorey G, Redfern J. The mobile revolution--using smartphone apps to prevent cardiovascular disease. Nat Rev Cardiol. 2015;12:350-360.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-3104.
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255-323.
Downloads
Published
How to Cite
License
Copyright (c) 2022 Juan Ruiz-García, Diana Molina Villaverde
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
